AUM Biosciences contributes to the discussion on the rise of medtech companies targeting solutions for Asia-prevalent cancers in a feature article on Bloomberg

https://www.bloomberg.com/news/articles/2018-10-02/asian-patients-finally-have-medicines-designed-for-them